{{Rsnum
|rsid=12198063
|Chromosome=6
|position=76581082
|Orientation=plus
|GMAF=0.07163
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 78.8 | 21.2 | 0.0
| HCB | 82.2 | 17.0 | 0.7
| JPT | 90.1 | 9.9 | 0.0
| YRI | 98.6 | 1.4 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 82.2 | 17.0 | 0.7
| CHD | 85.2 | 14.8 | 0.0
| GIH | 82.2 | 17.8 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 94.8 | 5.2 | 0.0
| MKK | 94.2 | 5.8 | 0.0
| TSI | 88.2 | 11.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=8E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}